InsidersTradesSigma
Browse the full record of transactions filed by Cory David A, Chief Executive Officer. Officer active across 1 companies, notably Eiger BioPharmaceuticals, Inc.. Cumulatively, 1 disclosures have been published. The latest transaction was filed on 11 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
David A. Cory is President and CEO of Eiger BioPharmaceuticals, Inc. He is responsible for the strategic direction of the company and the management of its daily operations. David plays a crucial role in defining Eiger's vision and goals while overseeing the execution of growth strategies.